Sfoglia per Rivista VACCINE
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]
2017-01-01 Iro, Ma; Snape, Md; Voysey, M; Jawad, S; Finn, A; Heath, Pt; Bona, Gianni; Esposito, S; Diez Domingo, J; Prymula, R; Odueyungbo, A; Toneatto, D; Dull, P; Pollard, Aj
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination
2006-01-01 A., Castadello; E., BROCCA COFANO; R., Voltan; C., Triulzi; G., Altavilla; Laus, Michele; Sparnacci, Katia; M., Ballestri; L., Tondelli; C., Fortini; R., Gavioli; B., Ensoli; A., Caputo
Immunization with HIV-1 tat DNA Delivered by Novel Cationic Block Copolymers Greatly Enhances the CTL responses against Tat at Very Low DNA Doses
2003-01-01 A., Caputo; R., Gavioli; G., Altavilla; E., Broccacofano; C., Boarini; M., Betti; A., Castaldello; F., Lorenzini; F., Micheletti; A., Cafaro; Sparnacci, Katia; Laus, Michele; L., Tondelli; B., Ensoli
Immunization with Low Doses of HIV-1 tat DNA Delivered by Novel Cationic Block Copolymers Induces CTL Responses Against Tat
2003-01-01 A., Caputo; R., Gavioli; G., Altavilla; E., BROCCA COFANO; C., Boarini; M., Betti; A., Castadello; F., Lorenzini; F., Micheletti; A., Cafaro; Sparnacci, Katia; Laus, Michele; L., Tondelli; B., Ensoli
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration
2009-01-01 Caputo, A; Castaldello, A; Brocca Cofano, E; Voltan, R; Bortolazzi, F; Altavilla, G; Sparnacci, Katia; Laus, Michele; Tondelli, L; Gavioli, R; Ensoli, B.
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application
2002-01-01 Caputo, A.; Betti, M.; Altavilla, G.; Bonaccorsi, A.; Boarini, C.; Marchisio, M.; Buttò, S.; Sparnacci, Katia; Laus, Michele; Tondelli, L.; Ensoli, B.
Modelling patterns of clearance of HPV-16 infection and vaccination efficacy
2011-01-01 Baussano, Iacopo; Garnett, Geoff; Segnan, Nereo; Ronco, Guglielmo; Vineis, Paolo
Novel Biocompatible Anionic Polymeric Microspheres for the Delivery of the HIV-1 Tat Protein for Vaccine Application
2004-01-01 A., Caputo; E., BROCCA COFANO; A., Castadello; R., DE MICHELE; G., Altavilla; M., Marchisio; R., Gavioli; U., Rolen; L., Chiarantini; A., Cerasi; S., Dominici; M., Magnani; A., Cafaro; Sparnacci, Katia; Laus, Michele; L., Tondelli; B., Ensoli
Optimal vaccination choice, vaccination games, and rational exemption: An appraisal
2009-01-01 P., Manfredi; P., Della Posta; A., D'Onofrio; Centrone, Francesca; C., Meo; P., Poletti; Salinelli, Ernesto
Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine
2017-01-01 Donadei, Agnese; Balocchi, Cristiana; Romano, Maria R.; Panza, Luigi; Adamo, Roberto; Berti, Francesco; O'Hagan, Derek T.; Gallorini, Simona; Baudner, Barbara C.
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial
2017-01-01 Iro, Mildred A; Snape, Matthew D.; Voysey, Merryn; Jawad, Sena; Finn, Adam; Heath, Paul T.; Bona, Gianni; Esposito, Susanna; Diez Domingo, Javier; Prymula, Roman; Odueyungbo, Adefowope; Toneatto, Daniela; Dull, Peter; Pollard, Andrew J.
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice
2009-01-01 Voltan, R; Castaldello, A; BROCCA COFANO, E; DE MICHELE, R; Triulzi, C; Altavilla, G; Tondelli, L; Laus, Michele; Sparnacci, Katia; Reali, E; Gavioli, R; Ensoli, B; Caputo, A.
RotaTeq (R), a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe.
2009-01-01 Vesikari, T; Itzler, R; Karvonen, A; Korhonen, T; Van Damme, P; Behre, U; Bona, Gianni; Gothefors, L; Heaton, Pm; Dallas, M; Goveia, M. G.
THE USE OF HEPATITIS A VACCINATION IN ITALY: AN ECONOMIC EVALUATION
2003-01-01 Fucci, Stefania; Demicheli, V; Carniglia, E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402] | 1-gen-2017 | Iro, Ma; Snape, Md; Voysey, M; Jawad, S; Finn, A; Heath, Pt; Bona, Gianni; Esposito, S; Diez Domingo, J; Prymula, R; Odueyungbo, A; Toneatto, D; Dull, P; Pollard, Aj | |
| DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination | 1-gen-2006 | A., Castadello; E., BROCCA COFANO; R., Voltan; C., Triulzi; G., Altavilla; Laus, Michele; Sparnacci, Katia; M., Ballestri; L., Tondelli; C., Fortini; R., Gavioli; B., Ensoli; A., Caputo | |
| Immunization with HIV-1 tat DNA Delivered by Novel Cationic Block Copolymers Greatly Enhances the CTL responses against Tat at Very Low DNA Doses | 1-gen-2003 | A., Caputo; R., Gavioli; G., Altavilla; E., Broccacofano; C., Boarini; M., Betti; A., Castaldello; F., Lorenzini; F., Micheletti; A., Cafaro; Sparnacci, Katia; Laus, Michele; L., Tondelli; B., Ensoli | |
| Immunization with Low Doses of HIV-1 tat DNA Delivered by Novel Cationic Block Copolymers Induces CTL Responses Against Tat | 1-gen-2003 | A., Caputo; R., Gavioli; G., Altavilla; E., BROCCA COFANO; C., Boarini; M., Betti; A., Castadello; F., Lorenzini; F., Micheletti; A., Cafaro; Sparnacci, Katia; Laus, Michele; L., Tondelli; B., Ensoli | |
| Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration | 1-gen-2009 | Caputo, A; Castaldello, A; Brocca Cofano, E; Voltan, R; Bortolazzi, F; Altavilla, G; Sparnacci, Katia; Laus, Michele; Tondelli, L; Gavioli, R; Ensoli, B. | |
| Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application | 1-gen-2002 | Caputo, A.; Betti, M.; Altavilla, G.; Bonaccorsi, A.; Boarini, C.; Marchisio, M.; Buttò, S.; Sparnacci, Katia; Laus, Michele; Tondelli, L.; Ensoli, B. | |
| Modelling patterns of clearance of HPV-16 infection and vaccination efficacy | 1-gen-2011 | Baussano, Iacopo; Garnett, Geoff; Segnan, Nereo; Ronco, Guglielmo; Vineis, Paolo | |
| Novel Biocompatible Anionic Polymeric Microspheres for the Delivery of the HIV-1 Tat Protein for Vaccine Application | 1-gen-2004 | A., Caputo; E., BROCCA COFANO; A., Castadello; R., DE MICHELE; G., Altavilla; M., Marchisio; R., Gavioli; U., Rolen; L., Chiarantini; A., Cerasi; S., Dominici; M., Magnani; A., Cafaro; Sparnacci, Katia; Laus, Michele; L., Tondelli; B., Ensoli | |
| Optimal vaccination choice, vaccination games, and rational exemption: An appraisal | 1-gen-2009 | P., Manfredi; P., Della Posta; A., D'Onofrio; Centrone, Francesca; C., Meo; P., Poletti; Salinelli, Ernesto | |
| Optimizing adjuvants for intradermal delivery of MenC glycoconjugate vaccine | 1-gen-2017 | Donadei, Agnese; Balocchi, Cristiana; Romano, Maria R.; Panza, Luigi; Adamo, Roberto; Berti, Francesco; O'Hagan, Derek T.; Gallorini, Simona; Baudner, Barbara C. | |
| Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial | 1-gen-2017 | Iro, Mildred A; Snape, Matthew D.; Voysey, Merryn; Jawad, Sena; Finn, Adam; Heath, Paul T.; Bona, Gianni; Esposito, Susanna; Diez Domingo, Javier; Prymula, Roman; Odueyungbo, Adefowope; Toneatto, Daniela; Dull, Peter; Pollard, Andrew J. | |
| Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice | 1-gen-2009 | Voltan, R; Castaldello, A; BROCCA COFANO, E; DE MICHELE, R; Triulzi, C; Altavilla, G; Tondelli, L; Laus, Michele; Sparnacci, Katia; Reali, E; Gavioli, R; Ensoli, B; Caputo, A. | |
| RotaTeq (R), a pentavalent rotavirus vaccine: Efficacy and safety among infants in Europe. | 1-gen-2009 | Vesikari, T; Itzler, R; Karvonen, A; Korhonen, T; Van Damme, P; Behre, U; Bona, Gianni; Gothefors, L; Heaton, Pm; Dallas, M; Goveia, M. G. | |
| THE USE OF HEPATITIS A VACCINATION IN ITALY: AN ECONOMIC EVALUATION | 1-gen-2003 | Fucci, Stefania; Demicheli, V; Carniglia, E. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile